 lupu anticoagul inhibit vitro prostacyclin releas thrombosis-pron subset patient purpos effect lupu anticoagulant-contain sera endotheli prostacyclin gener basal thrombin stimul subset patient arteri venou thrombosi respect quantit antiphospholipid antibodi effect prostacyclin product patient method serum antiphospholipid antibodi patient immunolog enzyme-link immunosorb assay kinet anticoagul assay cultur human endotheli cell normal serum releas prostacyclin radioimmunoassay supernat releas absenc presenc secretagogu thrombin u/ml interassay variat clinic laboratori variabl result normal prostacyclin respons increas thrombin u/ml product patient histori arteri thrombosi group igg anticardiolipin antibodi titer OD prolong kaolin time second prostacyclin respons patient venou thrombosi group titer intermedi clot time second impair prostacyclin respons patient histori thrombosi group low antibodi titer time second normal prostacyclin respons patient serum basal arachidonate-induc prostacyclin product group platelet count group group similar age associ diagnos conclus inhibit prostacyclin respons serum patient lupu anticoagul like present patient high igg anticardiolipin antibodi strong lupu anticoagul low platelet count recent arteri thrombosi